Why is BMI an inadequate measure of health?

BMI uses only height and weight, so it cannot distinguish between muscle and fat. A muscular man can register as overweight or obese by BMI while having low body fat. Conversely, a man with a normal BMI can carry high levels of visceral fat. Research has shown that fat distribution and metabolic markers are more meaningful indicators of health risk than BMI alone.

Can blood work reveal why my body composition is changing?

Yes. A targeted blood panel can identify clinical factors that drive body composition changes, including insulin resistance, thyroid dysfunction, hormonal imbalances, and chronic inflammation. These markers help explain why your body may be storing more fat or losing lean mass, providing actionable clinical information beyond what body composition measurements alone can show.

Body Composition Assessment for Men | regeniq

Why Body Composition Matters More Than Body Weight

Body weight is a single aggregate number that collapses multiple distinct tissue compartments into one reading. It cannot distinguish between muscle, fat, water, and bone. A man gaining visceral fat while losing lean mass can maintain a stable scale weight while his metabolic health deteriorates underneath. This is why BMI, which relies solely on height and weight, is increasingly recognised as an inadequate measure of health. The clinically meaningful question is not how much a person weighs, but how that weight is partitioned between metabolically protective tissue (lean mass) and metabolically harmful tissue (visceral fat).

The Problem with BMI

Body Mass Index was developed in the 1830s as a population-level statistical tool. It was never designed to assess individual health, and applying it at that level introduces systematic errors. A muscular man who trains regularly can register a BMI in the overweight or obese range while carrying low body fat and demonstrating excellent metabolic markers. Conversely, a man with a normal BMI can harbour dangerous levels of visceral fat around his organs.

Published research has documented that anthropometric measures like BMI fail to capture the metabolic risk associated with fat distribution. This matters because the body does not store fat uniformly. Visceral fat, which accumulates around the abdominal organs, is metabolically active and produces inflammatory cytokines that elevate cardiovascular and metabolic risk. Where fat accumulates is driven by hormonal signalling, insulin sensitivity, and other physiological factors that BMI ignores entirely. The mechanism matters: two men at the same BMI can face very different risk profiles depending on how their bodies partition energy storage.

Visceral Fat, Lean Mass, and Metabolic Risk

Visceral fat is not simply stored energy waiting to be used. It functions as an active endocrine organ, producing inflammatory compounds, disrupting insulin signalling, and affecting hormonal balance. Men with elevated visceral fat relative to their body weight carry increased risk for metabolic syndrome, cardiovascular disease, and type 2 diabetes, regardless of what the scale reads.

Lean mass operates as the metabolic counterpart. Muscle tissue is metabolically active, may improve insulin sensitivity, supports hormonal health, and contributes to functional capacity across the lifespan. The ratio between lean mass and fat mass provides a more meaningful measure of health than total body weight alone.

The critical pattern to understand is this: when body composition shifts toward more visceral fat and less lean mass, even at a stable total weight, your metabolic health may be declining. This is a dose-response relationship. Small, sustained shifts in the lean-to-fat ratio can compound into measurable metabolic changes over months and years. A clinical body composition assessment is designed to detect this pattern before it progresses to overt disease.

What a Clinical Body Composition Assessment Involves

A clinical body composition assessment goes beyond stepping on a scale. It combines objective body composition data with a comprehensive blood panel to understand not just the observable pattern of your body composition, but the underlying metabolic and hormonal drivers producing that pattern. The goal is systematic: identify the highest-priority physiological constraints first, then work down the hierarchy.

Metabolic and Hormonal Markers

Body composition is governed by a hierarchy of physiological factors, and blood work can reveal where that hierarchy is constrained. A targeted panel may include fasting glucose, fasting insulin, and HbA1c to assess insulin sensitivity and glucose regulation. Thyroid function tests evaluate metabolic rate. Key hormonal markers, including testosterone and cortisol, both affect muscle-to-fat partitioning. Inflammatory markers like C-reactive protein assess whether chronic inflammation is contributing to adverse body composition changes.

These markers serve the same function as a diagnostic sequence: they help your practitioner identify the specific physiological system driving your body composition pattern, rather than guessing based on surface-level observations. The mechanism matters. Insulin resistance, for instance, shifts the body's energy partitioning toward fat storage and away from lean tissue maintenance. Identifying that mechanism changes the entire clinical approach.

Interpreting the Results

The value of a clinical assessment lies in integrated interpretation. Your practitioner reviews blood work alongside body composition data, health history, training habits, and symptoms, looking for the causal chain: is insulin resistance driving fat storage? Are declining hormonal markers reducing lean mass? Is chronic inflammation creating a cycle of metabolic dysfunction that compounds over time?

This integrated view is what standard blood work and standard body composition measurements, taken in isolation, cannot provide. Two men with identical body fat percentages can have completely different clinical pictures and completely different underlying drivers. One may have a primarily metabolic constraint; another may have a hormonal constraint; a third may have adequate metabolic and hormonal function with the issue sitting higher in the lifestyle hierarchy. The blood work reveals which system is actually constrained, and that determines what intervention, if any, may be appropriate.

What Happens After Your Assessment

Based on your combined assessment, your practitioner discusses findings and, where clinically appropriate, may develop a personalised management plan. This plan targets the specific physiological drivers behind adverse body composition changes, whether metabolic dysfunction, hormonal imbalance, or chronic inflammation, rather than applying a generic calorie target.

Some patients discover that their body composition changes have a clear clinical driver that targeted intervention may address. Others learn that their metabolic profile is actually healthy and the constraint sits in training, nutrition, or recovery factors. Both outcomes have clinical value, because identifying where the system is not constrained is just as important as identifying where it is. Without that clarity, effort gets directed at the wrong level of the hierarchy.

Follow-up assessments track changes in both body composition and metabolic markers over time. This allows your practitioner to measure whether the clinical approach is producing the expected physiological response, and to adjust the plan based on observed outcomes rather than assumptions.

Risks and Considerations

Any clinical intervention carries potential risks. Your practitioner will discuss specific risks and potential side effects relevant to your situation during your consultation. All prescribing follows TGA-compliant pathways, and your practitioner will explain the regulatory framework that governs any clinical recommendation. Not all patients are suitable candidates for every approach. Pre-existing conditions, current medications, and individual health factors all influence clinical decisions. Your practitioner may recommend lifestyle modifications, referral to a dietitian or exercise physiologist, coordination with your GP, or specialist referral rather than starting a clinical management plan. Body composition outcomes depend on many factors. Individual results vary. No outcome is guaranteed.

Frequently Asked Questions

BMI uses only height and weight, collapsing distinct tissue types into a single number. It cannot distinguish between muscle and fat. A muscular man can register as overweight or obese by BMI while carrying low body fat and healthy metabolic markers. Conversely, a man with a normal BMI can carry high levels of visceral fat. Research has shown that fat distribution, lean mass ratio, and metabolic markers are more meaningful indicators of health risk than BMI alone, because they reflect how the body is actually partitioning energy and tissue.

Visceral fat accumulates around the abdominal organs and functions as a metabolically active endocrine organ. Unlike subcutaneous fat (stored under the skin), visceral fat produces inflammatory compounds that disrupt insulin signalling, affect hormonal balance, and contribute to elevated cardiovascular and metabolic risk. The relationship is dose-dependent: as visceral fat increases, so does the inflammatory and metabolic burden. Men can carry clinically significant levels of visceral fat without appearing noticeably overweight, which is why clinical measurement rather than visual assessment is important.

A targeted blood panel can identify the specific physiological factors driving body composition changes, including insulin resistance, thyroid dysfunction, hormonal imbalances, and chronic inflammation. These markers reveal the mechanism behind the observable pattern. For instance, if insulin sensitivity is impaired, the body may preferentially partition energy toward fat storage rather than lean tissue maintenance. Identifying the constrained system provides actionable clinical information that body composition measurements alone cannot, and it directs clinical attention to the highest-priority intervention.

References

^[1] Santhanam P, et al. "Artificial intelligence and body composition." Diabetes and Metabolic Syndrome, vol. 17, no. 3, 2023, p. 102732. [Link]
^[2] Yan LJ, et al. "Anthropometric indicators of adiposity and risk of primary liver cancer: BMI limitations." European Journal of Cancer, vol. 185, 2023, pp. 150-163. [Link]
^[3] Grossmann M, et al. "Late-onset hypogonadism: metabolic impact." Andrology, vol. 8, no. 6, 2019, pp. 1519-1529. [Link]

Registered Body Composition Consultations Across Australia

Regeniq is a registered Australian telehealth clinic offering practitioner-led medical consultations for men's body composition and metabolic health. Every consultation is conducted by an AHPRA-registered practitioner via live video, meeting the same clinical standard as a face-to-face appointment. Our licensed practitioners can prescribe through TGA-compliant pathways, and where clinically appropriate, prescriptions may be dispensed through a registered compounding pharmacy staffed by licensed pharmacists. Our clinical approach follows a systematic hierarchy: a thorough medical consultation first reviews your symptoms, health history, and relevant pathology, including metabolic, hormonal, and inflammatory panels. This builds a complete clinical picture, identifying which physiological systems may be constrained, before any recommendations are made. All care is coordinated with your existing GP where appropriate. If you are searching for a registered, evidence-based telehealth clinic for body composition and metabolic assessment in Australia, our AHPRA-registered practitioners consult nationwide.

medically supervised weight management for men

medically supervised weight management

understanding growth hormone and body composition

Ready for a clinical assessment?

Want to learn more about evidence-based telehealth?

Body Composition and Metabolic Health Assessment